ZAMELINE 1 mg/ml, eye drop solution
Active ingredients: Hexamidine diisethionate, Hexamidine
Commercialized according to BDPM
Eye drop solution10 (2 x 5) récipient(s) multidose(s) polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) de 0,6 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZAMELINE 1 mg/mL, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 10 (2 x 5) récipient(s) multidose(s) polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) de 0,6 ml
- Marketing authorisation holder
- THEA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 7 Jul 2025
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66147346CIP73025721CIP133400930257210Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DIISÉTHIONATE D'HEXAMIDINEcollyre | 1 mg · 1 mL de solution | SA |
| HEXAMIDINEcollyre | 0,58 mg · 1 mL de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.